Metabolite Profiling, In-vitro Anticancer Activity of Jatropha heynei Followed by Molecular Docking Studies

Authors

  • Ashoka B. Gowdru Department of P.G. Studies and Research in Applied Botany, Kuvempu University, Shankaraghatta, Shimoga, Karnataka, India
  • Shivanna B. Manchanahally Department of P.G. Studies and Research in Applied Botany, Kuvempu University, Shankaraghatta, Shimoga, Karnataka, India

Abstract

Jatropha heynei of family Euphorbiaceae is an endemic herb with ethno-medicinal values. The present study investigates the phytochemical profiling, in-vitro anticancer activity against Dalton’s lymphoma ascites (DLA) and ehrlich’s ascites carcinoma (EAC) cell lines and in-silico molecular docking analysis of isolated chemicals of J. heynei tuber ethanolic extract. High resolution liquid chromatograph mass spectrometer (HR-LCMS) analysis of ethanolic tuber extract revealed the presence of 19 prominent phytochemical compounds. Six compounds meptazinol, 8-amino-7-oxononanoate, dihydrodeoxystreptomycin, albendazol (II), hydroxytinidazole, azoprocarbazine were present in high quantity, of which azoprocarbazine was shown with anticancer activity. There were several compounds with a number of other therapeutic properties. The ethanolic extract of J. heynei tuber showed significant in-vitro cytotoxic activity against DLA (IC50=64.14 μg mL-1) and EAC (IC50=71.42 μg mL-1) cancer cell lines, almost comparable to the value of standard curcumin (IC50=54.36 μg mL-1). Molecular docking and in-silico analysis of the compounds such as azoprocarbazine, ecgonine and meptazinol displayed strong interactions with the anticancer target proteins such as vascular endothelial growth factor (VEGF), tyrosine kinase (TK), and matrix metalloproteins (MMP) when compared with their respective drug inhibitors pazopanib, imatinib and batimastat. Compounds with wide range of biological activities suggested that J. heynei could be exploited for formulating new drugs in the treatment of several diseases and disorders.

Keywords:

Jatropha heynei, Euphorbiacae, in-vitro anticancer activity, cancer cell lines, in-silico molecular docking, chemical profiling.

DOI

https://doi.org/10.25004/IJPSDR.2022.140622

References

Sabandar CW, Ahmat N, Jaafar FM, Sahidin I. Medicinal property, phytochemistry and pharmacology of several Jatropha species (Euphorbiaceae): A review. Photochemistry 2013; 85:7-29. Available from: doi.org/10.1016/j.phytochem.2012.10.009

Mohan RK and Bhirava Murthy PV. Plants used in traditional medicine by tribals of Prakasam district, Andhra Pradesh. Ancient science of life 1992; 11(3-4): 176.

Cavalcante NB, da Conceição Santos AD, da Silva Almeida JRG. The genus Jatropha (Euphorbiaceae): A review on secondary chemical metabolites and biological aspects. Chemico-Biological Interactions 2020; 318: 108976. Available from: doi.org/10.1016/j. cbi.2020.108976

Hegedűs C, Kovács K, Polgár Z, Regdon Z, Szabó É, Robaszkiewicz A, Virág L. Redox control of cancer cell destruction. Redox biology 2018; 16: 59-74. Available from: doi.org/10.1016/j.redox.2018.01.015

Chakravarti B, Maurya R, Siddiqui JA, Bid HK, Rajendran SM, Yadav PP, Konwar R. In-vitro anti-breast cancer activity of ethanolic extract of Wrightia tomentosa: role of pro-apoptotic effects of oleanolic acid and urosolic acid. Journal of ethnopharmacology 2012; 142(1): 72-79. Available from: doi.org/10.1016/j.jep.2012.04.015

Ubhenin A, Uwakwe A, Falodun A, Engel N, Onwuka F, Langer P. Anti-proliferative and pro-apoptotic effects of Caesalpinia bonduc extract and its fractions in estrogen-sensitive human breast adenocarcinoma cell line. Journal of herbs, spices and medicinal plants 2013; 19(2): 159-167. Available from: doi.org/10.1080/104 96475.2012.762725

Thirumurugan K. Antimicrobial activity and phytochemical analysis of selected Indian folk medicinal plants. Steroids 2010; 1(7): 430-434.

Cragg GM, Newman DN, Weiss RB. Coral reefs, forests, and thermal vents: the worldwide exploration of nature for novel anticancer agents. Semi Oncol 1997; 24:156–63.

Shweta S, Gurumurthy BR, Ravikanth G, Ramanan US, Shivanna MB. Endophytic fungi from Miquelia dentata Bedd, produce the anti-cancer alkaloid, camptothecine. Phytomedicine 2013; 20(3-4): 337-342. Available from: doi.org/10.1016/j.phymed.2012.11.015

Fang J, Liu C, Wang Q, Lin P, Cheng F. In silico polypharmacology of natural products. Briefings in bioinformatics 2018; 19(6): 1153- 1171. Available from: doi.org/10.1093/bib/bbx045

Tahir RA, Wu H, Javed N, Khalique A, Khan SAF, Mir A, Sehgal SA. Pharmaco-informatics and molecular docking reveal potential drug candidates against Schizophrenia to target TAAR6. Journal of cellular physiology 2019; 234(8): 13263-13276. Available from: doi.org/10.1002/jcp.27999

Komuraiah B, Chinde S, Kumar AN, Srinivas KS, Venu C, Kotesh J. Phytochemicals from anticancer active phytochemicals from anticancer active Jatropha heynei N. P. Balakr. Elsevier B. 2014; 93.

Gamble JS. Flora of the Presidency of Madras 1934; vol. II: 1339. Bot. Survey of India.

De Castro ML and Garcıa-Ayuso LE. Soxhlet extraction of solid materials: an outdated technique with a promising innovative future. Analytica chimica acta 1998; 369(1-2): 1-10. Available from: doi.org/10.1016/S0003-2670(98)00233-5

Kokate CK, Purohit AP, Ghokhale SB. Pharmacognosy. Nirali Prakashan, Pune, India 1997.

Talwar GP. Handbook of practical immunology. Vikas Publishing House 1983.

Gupta SK, Talwar GP, Gupta SK. In Cytotoxicity Assays: A Handbook of practical and Clinical Immunology, 2nd edition. CBS, New Delhi 2002: 299 - 300.

Mills N. Chem Draw Ultra 10.0 Cambridge Soft, 100 Cambridge Park Drive, Cambridge 2006. MA 02140. Www.cambridgesoft.com. Commercial Price: 1910 for download, 2150 for CD-ROM; Academic Price: 710 for download, 800 for CD-ROM. Available from: doi. org/10.1021/ja0697875

O'Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR. Open Babel: An open chemical toolbox. Journal of cheminformatics 2011; 3(1): 33. Available from: doi:10.1186/1758- 2946-3-33

Huey R, Morris GM, Olson AJ, Goodsell DS. A semiempirical free energy force field with charge‐based desolvation. Journal of computational chemistry 2007; 28(6): 1145-1152. Available from: doi.org/10.1002/jcc.20634

Daina A, Michielin O, Zoete V. Swiss ADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017; 7:42717. Available from: DOI: 10.1038/srep42717

Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv Rev 2001; 46: 3–26. Available from: doi.org/10.1016/j.addr.2012.09.019

Ghose AK, Viswanadhan VN, Wendoloski JJ. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. A qualitative and quantitative characterization of known drug databases. Journal of combinatorial chemistry 1999; 1(1): 55-68. Available from: doi.org/10.1021/ cc9800071

Veber DF, Johnson SR, Cheng HY, Smith BR, Ward KW, Kopple KD. Molecular properties that influence the oral bioavailability of drug candidates. Journal of medicinal chemistry 2002; 45(12): 2615- 2623. Available from: doi.org/10.1021/jm020017n

Egan WJ, Merz KM, Baldwin JJ. Prediction of drug absorption using multivariate statistics. Journal of medicinal chemistry 2000; 43(21): 3867-3877. Available from: doi.org/10.1021/jm000292e

Muegge I, Heald SL, Brittelli D. Simple selection criteria for drug-like chemical matter. Journal of medicinal chemistry 2001; 44(12): 1841-1846. Available from: doi.org/10.1021/jm015507e

Volkamer A , Kuhn D, Grombacher T, R ippmann F, R arey M. Com¬bining global and local measures for structure-based druggability predictions. Journal of chemical information and modelling 2012; 52(2): 360-372. Available from: doi.org/10.1021/ci200454v

Trott O, Olson AJ. Auto Dock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of computational chemistry 2010; 31(2): 455-461. Available from: doi.org/10.1002/jcc.21334

Biovia DS. Discovery studio visualizer 2017. San Diego, CA, USA, 936.

Lee SK, Lee IH, Kim H, Chang GS, Chung JE, No KT. The Pre ADME Approach: Web-based program for rapid prediction of physico-chemical, drug absorption and drug-like properties. Euro QSAR designing drugs and crop protectants. Processes, problems and solutions 2003; 418-20.

Ghasemzadeh A, Jaafar HZE, Rahmat A. Antioxidant activities, total phenolics a nd f lavonoids c ontent i n t wo v arieties o f M alaysia Young G inger ( Zingiber o fficinale R oscoe). M olecules 2 010; 1 5: 4324-4333. Available from: doi.org/10.3390/molecules15064324

Tapas AR, Sakarkar DM, Kakde RB. Flavonoids as Nutraceuticals: A Review. Tropical Journal of Pharmaceutical Research 2008; 7: 1089- 1099. Available from: doi.org/10.4314/tjpr.v7i3.14693

Wink M, Schmeller T, Latz-Briining B. Modes of action of allelochemi¬cal alkaloids: Interaction with neuro-receptors, DNA and other molecular targets. Journal of chemical Ecology 1998; 24: 1888-1937.

Swaffar DS, Horstman MG, Jaw JY, Thrall BD, Meadows GG, Harker WG, Yost GS. Methylazoxyprocarbazine, the active metabolite responsible for the anticancer activity of procarbazine against L1210 leukemia. Cancer research 1989; 49(9): 2442-2447.

Somers LM. Benzoylecgonine, benzoylnorecgonine and ecgonine as active agents for the treatment of rheumatoid arthritis and osteoarthritis. U.S. Patent No. 4556663; 1985.

Holmes B and Ward A. Meptazinol. Drug 1985; 30(4): 285-312.

De Groot DJA, De Vries EGE, Groen HJM, De Jong S. Non-steroidal anti-inflammatory drugs to potentiate chemotherapy. From lab to clinic. Crit. Rev. Oncol. Hematol 2007; 61: 52–69. Available from: doi.org/10.1016/j.critrevonc.2006.07.001

Ebner F, Heller A, Rippke F, Tausch I. Topical use of dexpanthenol in skin disorders. American journal of clinical dermatology 2002; 3(6): 427-433. Available from: doi:10.2165/00128071-200203060-00005

Biro K, Thaci D, Ochsendorf FR, Kaufman R, Boehncke WH. Efficacy of dexpanthenol in skin protection against irritation: a double‐blind, placebo‐controlled study. Contact dermatitis 2003; 49(2): 80-84. Available from: doi.org/10.1111/j.0105-1873.2003.00184.x

Webster SP, Alexeev D, Campopiano DJ, Watt RM, Alexeeva M, Sawyer L, Baxter RL. Mechanism of 8-amino-7-oxononanoate synthase: spectroscopic, kinetic, and crystallographic studies. Biochemistry 2000; 39(3): 516-528. Available from: doi.org/10.1021/bi991620j

Manes G and Balzano A. Tinidazole: From protozoa to Helicobacter pylori-the past, present and future of a nitro imidazole with peculiarities. Expert Rev Anti Infect Tker 2004; 2:695-705. Available from: doi.org/10.1586/14789072.2.5.695

Ikeda H, Shiroyanagi K, Tsuji KI, Katayama M, Fujimaki I, Sato T. Dihydro-desoxystreptomycin, a New Reduction Product of Streptomycin Proceedings of the Japan Academy 1956; 32(1): 53-58. Available from: doi.org/10.2183/pjab1945.32.53

Horton J. Albendazole: a review of anthelmintic efficacy and safety in humans. Parasitology 2000; 121(S1): S113-S132. Available from: doi.org/10.1017/S0031182000007290

Azad I, Nasibullah M, Khan T, Hassan F, Akhter Y. Exploring the novel heterocyclic derivatives as lead molecules for design and development of potent anticancer agents. Journal of Molecular Graphics a nd M odelling 2 018; 8 1: 2 11-228. Available f rom: d oi. org/10.1016/j.jmgm.2018.02.013

Ripphausen P, Stumpfe D, Bajorath J. Analysis of structure-based virtual screening studies and characterization of identified active compounds. Future Medicinal Chemistry 2012; 4(5): 603-613. Available from: doi.org/10.4155/fmc.12.18

Nisha CM, Kumar A, Nair P, Gupta N, Silakari C, Tripathi T, Kumar A. Molecular docking and in silico ADMET study reveals acylguanidine 7a as a potential inhibitor of β-secretase. Advances in bioinformatics 2016. Available from: doi.org/10.1155/2016/9258578

Onawole AT, Kolapo TU, Sulaiman KO, Adegoke RO. Structure based virtual screening of the Ebola virus trimeric glycoprotein using consensus scoring. Computational biology and chemistry 2018; 7 2: 1 70 -180. A v a i lable f r om: d oi .or g /10.1016/j. compbiolchem.2017.11.006

Encinar JA, Fernández-Ballester G, Galiano-Ibarra V, Micol V. In silico approach for the discovery of new PPARγ modulators among plant-derived polyphenols. Drug design, development and therapy 2015; 9: 5877. Available from: dx.doi.org/10.2147/DDDT.S93449

Hay M, Thomas DW, Craighead JL, Economides C, Rosenthal J. Clinical development success rates for investigational drugs. Nature biotechnology 2014; 32(1): 40-51.

Raj U, Kumar H, Gupta S, Varadwaj PK. Novel DOT1L receptor natural inhibitors involved in mixed lineage leukemia: a virtual screening, molecular docking and dynamics simulation study. Asian Pac J. Cancer Prev 2015; 16(9): 3817-3825. Available from: doi.org/10.7314/APJCP.2015.16.9.3817

Hiraok a T, K ihira K , K ajiyama G, Kuramoto T, Hoshit a T. Identification of 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 24, 25, 26-hexol in human urine. Journal of Lipid Research 1987; 28(8): 895-899. Available from: doi.org/10.1016/S0022-2275(20)38635-1

Nielsen JM, Brandt K, Hansen J. Long-term effects of thidiazuron are intermediate between benzyladenine, kinetin or isopentenyladenine in Miscanthus sinensis. Plant Cell, Tissue and Organ Culture 1993; 35(2): 173-179. Available from: doi:10.1007/bf00032967

Published

30-11-2022
Statistics
Abstract Display: 400
PDF Downloads: 394
Dimension Badge

How to Cite

“Metabolite Profiling, In-Vitro Anticancer Activity of Jatropha Heynei Followed by Molecular Docking Studies”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 14, no. 6, Nov. 2022, pp. 833-42, https://doi.org/10.25004/IJPSDR.2022.140622.

Issue

Section

Research Article

How to Cite

“Metabolite Profiling, In-Vitro Anticancer Activity of Jatropha Heynei Followed by Molecular Docking Studies”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 14, no. 6, Nov. 2022, pp. 833-42, https://doi.org/10.25004/IJPSDR.2022.140622.